Xevinapant plus Chemoradiotherapy Negatively Sculpts the Tumor-Immune Microenvironment in Head and Neck CancerCharleen Chan Wah Hak(Institute of Cancer Research), Kevin J. Harrington(Royal Marsden NHS Foundation Trust)Cancer Research CommunicationsOctober 22, 202510.1158/2767-9764.crc-25-0604Cited by 1SaveCiteExport RISWatch citationsRelated PapersCancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances|Oncolytic Virotherapy|2016|75Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway|BMC Cancer|2012|62Delayed DNA double-strand break repair following platin-based chemotherapy predicts treatment response in head and neck squamous cell carcinoma|British Journal of Cancer|2016|18